In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation

Yuta Kato; Atsushi Iwata; Masayuki Nakamura; Shin-ichiro Miura; Keijiro Saku

首页> 外文期刊>Journal of Clinical Medicine Research >In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation

【24h】

In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation

机译：第三代药物洗脱支架植入后由于支架后坐力引起的支架内再狭窄

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A 72-year-old man with a heavily calcified coronary lesion underwent percutaneous coronary intervention (PCI) using a third-generation drug-eluting stent (DES) with thin stent struts. Two months after the PCI, in-stent restenosis due to stent recoil (SR) occurred. An intravascular ultrasound (IVUS) revealed deformed stent struts and heavily calcified coronary plaque. The SR probably occurred due to persistent vessel compression as a result of heavily calcified coronary plaque. We should consider using a DES with thick stent struts rather than a third-generation DES with thin stent struts in patients with a heavily calcified coronary lesion.J Clin Med Res. 2017;9(6):534-538doi: https://doi.org/10.14740/jocmr3024w

机译：一名患有严重钙化病变的72岁男性接受了第三代药物洗脱支架（DES）和薄支架支撑的经皮冠状动脉介入治疗（PCI）。 PCI后两个月，发生了由于支架后坐力（SR）引起的支架内再狭窄。血管内超声（IVUS）显示支架支杆变形和严重钙化的冠状动脉斑块。 SR可能是由于严重钙化的冠状动脉斑块导致持续的血管受压所致。对于冠状动脉钙化严重的患者，我们应该考虑使用具有较厚支架支架的DES，而不是使用具有较薄支架支架的第三代DES。 2017; 9（6）：534-538doi：https://doi.org/10.14740/jocmr3024w

著录项

来源
《Journal of Clinical Medicine Research》 |2017年第6期|共5页
作者
Yuta Kato; Atsushi Iwata; Masayuki Nakamura; Shin-ichiro Miura; Keijiro Saku;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: From Western Denmark heart registry [J] . JensenJ.K., JensenL.O., TerkelsenC.J., Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions . 2013,第2期

机译：药物洗脱支架植入术治疗冠状动脉支架内再狭窄后明确的支架血栓或支架内再狭窄的发生率：来自西丹麦心脏登记
2. Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent [J] . Heng Ge, Qing Zhang, Wei Zhou, Journal of Zhejiang University. Science, B . 2010,第8期

机译：药物洗脱支架植入治疗在裸金属支架和药物洗脱支架中发生的支架再狭窄的疗效和安全性
3. Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent [J] . Heng GE, Qing ZHANG, WeiZHOU, 浙江大学学报：B卷英文版 . 2010,第008期

机译：药物洗脱支架植入术治疗裸金属支架和药物洗脱支架内支架内再狭窄的疗效和安全性
4. Coronary in-stent restenosis after sirolimus-eluting stent implantation is accompanied by elevated plasma level of eosinophil cationic protein [C] . Gabbasov Z., Kozlov S., Imaeva A., International Congress on Coronary Artery Disease . 2011

机译：冠状动脉内再狭窄在西罗莫司洗脱支架植入后伴随着嗜酸性粒细胞阳离子蛋白的血浆水平升高
5. Risk of major adverse cardiovascular events with in-stent restenosis of bare metal stents. [D] . Mahapatra, Ena. 2010

机译：裸金属支架支架内再狭窄会导致重大不良心血管事件的风险。
6. In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation [O] . Yuta Kato, Atsushi Iwata, Masayuki Nakamura, 2017

机译：第三代药物洗脱支架植入后由于支架后坐力引起的支架内再狭窄
7. Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent* [O] . Ge, Heng, Zhang, Qing, Zhou, Wei, 2010

机译：药物洗脱支架植入术治疗裸金属支架和药物洗脱支架内发生支架内再狭窄的疗效和安全性*

In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation

摘要

著录项

相似文献

相关主题

期刊订阅